21Shares Revamps Injective ETF Filing with Nasdaq Ticker TINJ

21Shares has filed an amended registration statement for its proposed Injective ETF, seeking to list it on Nasdaq under the ticker TINJ. The fund would track INJ through the FTSE Injective Index and provide investors with exposure to the INJ token through a traditional exchange-traded product.

The amended filing updates the product structure but does not amount to launch approval. 21Shares is still finalizing custody arrangements, which could affect review timing and the final form of the product.

The proposed Injective ETF is part of 21Shares' expansion into single-asset crypto ETFs in the U.S. market. The issuer has previously filed for other digital assets such as Dogecoin and Hyperliquid, suggesting it continues to test demand for crypto funds beyond the largest tokens.